Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders

Jacob Cohen, Zelan Wei, Jonathan Phang, Robert B. Laprairie, Yanbo Zhang

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

9 Citas (Scopus)

Resumen

Posttraumatic Stress Disorder (PTSD) is a leading psychiatric disorder that mainly affects military and veteran populations but can occur in anyone affected by trauma. PTSD treatment remains difficult for physicians because most patients with PTSD do not respond to current pharmacological treatment. Psychotherapy is effective, but time consuming and expensive. Substance use disorder is often concurrent with PTSD, which leads to a significant challenge for PTSD treatment. Cannabis has recently received widespread attention for the potential to help many patient populations. Cannabis has been reported as a coping tool for patients with PTSD and preliminary legalization data indicate Cannabis use may reduce the use of more harmful drugs, such as opioids. Rigorous clinical studies of Cannabis could establish whether Cannabis-based medicines can be integrated into treatment regimens for both PTSD and substance use disorder patients.

Idioma originalEnglish
Páginas (desde-hasta)28-34
Número de páginas7
PublicaciónJournal of Clinical Neurophysiology
Volumen37
N.º1
DOI
EstadoPublished - ene. 1 2020

Nota bibliográfica

Funding Information:
J. Cohen is supported by Department of Psychiatry Intramural Awards, Kripa Thaur Memorial Award, Royal Canadian Legion Bursary, and MITACS Accelerate Master’s Fellowship. R. B. Laprairie is supported by a partnership char from GlaxoSmithKline and the Canadian Institutes of Health Research, and grants from the College of Pharmacy and Nutrition, NSERC, and the Saskatchewan Health Research Foundation. Y. Zhang is supported by the Iver and Joyce Graham Indiana Small Professorship, and grants from the Department of psychiatry and the College of Medicine, and the Saskatchewan Health Research Foundation. The authors have no conflicts of interest to disclose.

Publisher Copyright:
© 2019 by the American Clinical Neurophysiology Society.

ASJC Scopus Subject Areas

  • Physiology
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Huella

Profundice en los temas de investigación de 'Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders'. En conjunto forman una huella única.

Citar esto